A Sanofi Diabetes pilot support program—the CoSTARS Junior initiative—has been developed for children with diabetes (type 1 and 2) so they receive better coordinated, individualised care.
The CoSTARS Junior program is intended to provide an additional resource to complement the patients’ diabetes support network by offering individualised support to assist children younger than 18 who are on Lantus (insulin glargine) and/or Apidra (insulin glulisine).
The program provides tailored, educational and emotional support strategies for children, parents and school staff about diabetes management; and teaches them how to inject insulin correctly.
A paediatric endocrinologist will appoint a credentialled diabetes educator who will monitor the child’s progress following the instructions from the GP. The CDE will make an initial home visit; followed by visits with the family to the child’s school; and follow up phone calls to ensure the family is comfortable with the customised, diabetes management plan.
According to paediatric Endocrinologist, Dr Andrew Cotterill, the program addresses an unmet need: providing an additional support mechanism for the treatment of juvenile diabetes, and can place young patients on the right path from first diagnosis.
“The development of a tailored care plan which involves the child’s physician and allied health providers is key to the child moving towards self-management and will help to increase their independence and self-esteem.”
Dr Cotterill says the program’s development has been quite long and it is gratifying to see it being rolled out.
Clinical nurse consultant for diabetes and endocrine, Marina Noud says the program ensures consistency of information and messages. “This is a key factor for its success as it enables close communication between the paediatric endocrinologist and CDE.
“Additionally, the child or family will receive calls or visits from their CDE. The CDE will help the child, family and school staff to use the child individualised plan to better manage diabetes in the school environment,” says Noud.
“Diabetes can be difficult to manage at any time in a person’s life but in children, and especially in teenagers, it can be a rollercoaster ride for the child and the family,” says Helen Kearney, clinical nurse consultant and credentialled diabetes educator.
“This program educates all facets of the child’s support networks including their teachers to ensure a holistic diabetes management plan,” says Kearney.
The CoSTARS Junior program is being showcased at the International Society for Paediatric and Adolescent Diabetes congress. The event will also see the launch a insulin delivery device for developed for children—the JuniorSTAR.
JuniorSTAR is a half-unit reusable insulin pen designed to suit the needs of young people helping them to take charge of their diabetes management. It provides young Type 1 and Type 2 diabetes patients with greater dosing flexibility due to the half unit dosing increments and improves accuracy and ease of use. JuniorSTAR is only intended to be used with Lantus (insulin glargine) or Apidra (insulin glulisine).
The JuniorSTAR pens will be distributed to healthcare professionals and diabetes nurses by the Sanofi team.